Cargando…

The Role of N6-Methyladenosine-Associated lncRNAs in the Immune Microenvironment and Prognosis of Colorectal Cancer

BACKGROUND: The role of N6-methyladenosine long noncoding RNAs (lncRNAs) in colorectal cancer (CRC) is elusive. MATERIALS AND METHODS: We identified m6A-associated lncRNAs by using the data gathered from The Cancer Genome Atlas (TCGA) and stratified CRC patients into different subgroups. Cox regress...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yuan, Congfei, Liu, Caidong, Zhao, Shuli, Zhang, Xishan, Jia, Haifeng, Chen, Baiyu, Zhang, Maojin, Zheng, Yuan, Zhou, Jin, Bo, Yanzhi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi 2022
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9470360/ https://www.ncbi.nlm.nih.gov/pubmed/36111241 http://dx.doi.org/10.1155/2022/4689396

Ejemplares similares

The functions of N6-methyladenosine modification in lncRNAs
por: He, Rong-Zhang, et al.
Publicado: (2020)

Comprehensive analysis of lncRNAs N(6)-methyladenosine modification in colorectal cancer
por: Zuo, Luo, et al.
Publicado: (2021)

Comprehensive Analysis and Prognosis Prediction of N6-Methyladenosine-Related lncRNAs in Immune Microenvironment Infiltration of Gastric Cancer
por: Huang, Jianfeng, et al.
Publicado: (2022)

N6-Methyladenosine-Related LncRNAs Are Potential Remodeling Indicators in the Tumor Microenvironment and Prognostic Markers in Osteosarcoma
por: Wu, Zhongguang, et al.
Publicado: (2022)

Ferroptosis-related lncRNAs guiding osteosarcoma prognosis and immune microenvironment
por: Yang, Mingyi, et al.
Publicado: (2023)

N6-Methyladenosine-Related lncRNAs Are Anticipated Biomarkers for Sarcoma Patients
por: Zhang, Xiaohe, et al.
Publicado: (2022)

N6-Methyladenosine-Related lncRNAs Are Potential Prognostic Biomarkers and Correlated With Tumor Immune Microenvironment in Osteosarcoma
por: Zheng, Di, et al.
Publicado: (2022)

Identification of N6-Methyladenosine-Related lncRNAs as a Prognostic Signature in Glioma
por: Chen, Yujia, et al.
Publicado: (2022)

N6-methyladenosine-related lncRNAs is a potential marker for predicting prognosis and immunotherapy in ovarian cancer
por: Nie, Xin, et al.
Publicado: (2022)

N6-methyladenosine-related lncRNAs in combination with computational histopathology and radiomics predict the prognosis of bladder cancer
por: Huang, Ziye, et al.
Publicado: (2022)

Tumor immune microenvironment lncRNAs
por: Park, Eun-Gyeong, et al.
Publicado: (2021)

Cuproptosis Combined with lncRNAs Predicts the Prognosis and Immune Microenvironment of Breast Cancer
por: Zhang, Liangping, et al.
Publicado: (2022)

Construction and Analysis of a Colorectal Cancer Prognostic Model Based on N6-Methyladenosine-Related lncRNAs
por: Zeng, Hanqian, et al.
Publicado: (2021)

Novel insights into mutual regulation between N(6)-methyladenosine modification and LncRNAs in tumors
por: Zhang, Nan, et al.
Publicado: (2023)

Novel insight into the functions of N6-methyladenosine modified lncRNAs in cancers (Review)
por: He, Yingjie, et al.
Publicado: (2022)

N(6)-Methyladenosine Regulators and Related LncRNAs Are Potential to be Prognostic Markers for Uveal Melanoma and Indicators of Tumor Microenvironment Remodeling
por: Liu, Zhicheng, et al.
Publicado: (2021)

N1-Methyladenosine-Related lncRNAs Are Potential Biomarkers for Predicting Prognosis and Immune Response in Uterine Corpus Endometrial Carcinoma
por: Liu, Jinhui, et al.
Publicado: (2022)

Identification of Epithelial-Mesenchymal Transition-Related lncRNAs that Associated With the Prognosis and Immune Microenvironment in Colorectal Cancer
por: Liu, Chuan, et al.
Publicado: (2021)

Prognosis analysis and validation of lipid metabolism-associated lncRNAs and tumor immune microenvironment in bladder cancer
por: Tan, Zhiyong, et al.
Publicado: (2023)

Novel pyroptosis-related lncRNAs and ceRNAs predict osteosarcoma prognosis and indicate immune microenvironment signatures
por: Yang, Mingyi, et al.
Publicado: (2023)

Cuproptosis-associated lncRNAs discern prognosis and immune microenvironment in sarcoma victims
por: Chu, Binxiang, et al.
Publicado: (2022)

Identification of Prognostic LncRNAs Subtypes Predicts Prognosis and Immune Microenvironment for Glioma
por: Chen, Fei, et al.
Publicado: (2022)

Integrated Analysis of N1-Methyladenosine Methylation Regulators-Related lncRNAs in Hepatocellular Carcinoma
por: Song, Danjun, et al.
Publicado: (2023)

The Effects of Autophagy-Related Genes and lncRNAs in Therapy and Prognosis of Colorectal Cancer
por: Yang, Yang, et al.
Publicado: (2021)

MicroRNAs/LncRNAs Modulate MDSCs in Tumor Microenvironment
por: Liu, Xiaocui, et al.
Publicado: (2022)

Identification of Tumor Microenvironment-Related Prognostic lncRNAs in Lung Adenocarcinoma
por: Yuan, Ligong, et al.
Publicado: (2021)

Development and validation of a ferroptosis-related lncRNAs signature to predict prognosis and microenvironment for melanoma
por: Ping, Shuai, et al.
Publicado: (2022)

A Ferroptosis-Related lncRNAs Signature Predicts Prognosis and Immune Microenvironment for Breast Cancer
por: Zhang, Kaiming, et al.
Publicado: (2021)

Retracted: Identification of Prognostic LncRNAs Subtypes Predicts Prognosis and Immune Microenvironment for Glioma
por: and Alternative Medicine, Evidence-Based Complementary
Publicado: (2023)

The role of lncRNAs in the tumor microenvironment and immunotherapy of melanoma
por: Zhou, Wencheng, et al.
Publicado: (2022)

Prognosis and Novel Drug Targets for Key lncRNAs of Epigenetic Modification in Colorectal Cancer
por: Zhang, Peng, et al.
Publicado: (2023)

Immune-Related LncRNAs Affect the Prognosis of Osteosarcoma, Which Are Related to the Tumor Immune Microenvironment
por: Huang, Qingshan, et al.
Publicado: (2021)

N6-Methyladenosine-Related lncRNAs Are Novel Prognostic Markers and Predict the Immune Landscape in Acute Myeloid Leukemia
por: Zhang, Lulu, et al.
Publicado: (2022)

The Prediction of Necroptosis-Related lncRNAs in Prognosis and Anticancer Therapy of Colorectal Cancer
por: Xiao, Hanyu, et al.
Publicado: (2022)

Pyroptosis-related lncRNAs: A novel prognosis signature of colorectal cancer
por: Cai, Xing, et al.
Publicado: (2022)

Comprehensive analysis of differences of N(6)-methyladenosine of lncRNAs between atrazine-induced and normal Xenopus laevis testis
por: Qi, Xuejie, et al.
Publicado: (2021)

N6-Methyladenosine-Related lncRNAs as potential biomarkers for predicting prognoses and immune responses in patients with cervical cancer
por: Zhang, He, et al.
Publicado: (2022)

Prognostic Value of N6-Methyladenosine-Related lncRNAs in Early-Stage Colorectal Cancer: Association With Immune Cell Infiltration and Chemotherapeutic Drug Sensitivity
por: Xiong, Zhizhong, et al.
Publicado: (2021)

Establishment of Prognostic Signatures of N6-Methyladenosine-Related lncRNAs and Their Potential Functions in Hepatocellular Carcinoma Patients
por: Wu, Xianbin, et al.
Publicado: (2022)

A Pan-Cancer Landscape of HOX-Related lncRNAs and Their Association With Prognosis and Tumor Microenvironment
por: Shao, Wei, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_bbg3e2m1rn1hidmj7r7pevgep1